Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study
Cancer Treatment and Research Communications · 2023
DOI: 10.1016/j.ctarc.2023.100781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2023. Verfasst von Jerome Desramé und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institut Privé de Cancérologie, Hôpital Privé Jean Mermoz, 55 Av. Jean Mermoz, 69373, Lyon 69008, France. Electronic address: jerome.desrame@orange.f…. Hauptthemen laut MEDLINE: Erythropoietin, Hematinics, Antineoplastic Agents, Anemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: Available tools to measure fatigue and health-related quality of life (HRQoL) in cancer patients are often difficult to use in clinical practice. The fatigue visual analogue scale (VAS) provides a simple method to assess fatigue. This study evaluated the correlation between HRQoL and fatigue perceived by cancer patients undergoing chemotherapy. METHODS: This was a non-interventional prospective study of adult cancer patients in France presenting with chemotherapy-induced anaemia (CIA) treated with epoetin alfa (Sandoz). Data were collected using an electronic case report form at study inclusion (T0), after 2-3 chemotherapy cycles (T1) and after 4-6 cycles (T2). RESULTS: The study included 982 patients from September 2015 to October 2017. Overall, there was a negative correlation between fatigue VAS and HRQoL. The overall haemoglobin (Hb) change between T0 and T2 was +17.8 % (± 18.1 %). Fatigue assessed by both patients and physicians showed a clinically significant improvement during the study. Global HRQoL also increased. CONCLUSION: Treatment of CIA with epoetin alfa (Sandoz) improved Hb levels, fatigue, and HRQoL, with a correlation observed between fatigue VAS score and HRQoL. Fatigue VAS could act as a simple alternative to more complex methods to measure HRQoL; however, further analyses are required to confirm this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Privé de Cancérologie, Hôpital Privé Jean Mermoz, 55 Av. Jean Mermoz, 69373, Lyon 69008, France. Electronic address: jerome.desrame@orange.fr.
- Centre Hospitalier Départemental Vendée, Bd Stéphane Moreau, La Roche-sur-Yon 85000, France.
- Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France; French National Platform Quality of Life and Cancer, Besançon, France; Department of Biostatistics, Centre Léon Bérard…
- Centre Hospitalier Le Mans, 194 Av. Rubillard, Le Mans 72037, France.
- Centre Hospitalier Annecy Genevois, 1 Av. De l'Hôpital, Epagny Metz-Tessy 74370, France.
- Sandoz, 49 Av. Georges Pompidou, Levallois-Perret 92300, France.
Zitieren
APA
Desramé, J., Baize, N., Anota, A., Laribi, K., Stefani, L., Hjiej, S., Nabirotchkina, E., Zelek, L., & Choquet, S. (2023). Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2023.100781
Vancouver
Desramé J, Baize N, Anota A, Laribi K, Stefani L, Hjiej S, et al. Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study. Cancer Treatment and Research Communications. 2023. doi:10.1016/j.ctarc.2023.100781
BibTeX
@article{Desram2023,
author = {Desramé, Jerome and Baize, Nathalie and Anota, Amélie and Laribi, Kamel and Stefani, Laetitia and Hjiej, Salim and Nabirotchkina, Ekatérina and Zelek, Laurent and Choquet, Sylvain},
title = {Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study},
journal = {Cancer Treatment and Research Communications},
year = {2023},
doi = {10.1016/j.ctarc.2023.100781}
}
EUVIMED